BENTONVILLE, Ariz., Feb. 27, 2018 -- via OTC PR WIRE-- Glucose Health, Inc. (OTC:GLUC) today announced the completion of its second TV commercial to support national expansion of its newest diabetic nutritional product, Glucose Health® Diabetic-Friendly Iced Tea. The key message to consumers of the 30 second commercial is “The Iced Tea That’s Good for You!”
The new TV commercial will be part of a national multi-channel media strategy to support Glucose Health® Diabetic-Friendly Iced Tea national sales expansion though “brick & mortar” retailer partners.
Watch the new TV commercial at the Glucose Health, Inc. corporate website at this link.
Glucose Health® Diabetic-Friendly Iced Tea Mix is more than just a delicious, sugar-free and decaffeinated iced tea – it’s also a potent nutritional supplement. Glucose Health® is enriched with key micronutrients relevant to persons concerned about diabetes, including Vitamins B6, B7, B12 and high bioavailability forms of the trace elements Manganese, Chromium and Zinc. Additionally, every serving of Glucose Health® Diabetic-Friendly Iced Tea includes 100% soluble fiber, clinically proven in research published in peer-reviewed medical journals to help “block” the body’s absorption of dietary sugars (and dietary fats) and to help moderate rising blood sugar levels, after meals.
About Glucose Health, Inc. (OTC:GLUC)
Glucose Health® Diabetic-Friendly Iced Tea Mix is a unique and compelling functional beverage which serves the fast-growing over-the-counter (non-prescription) diabetic nutritionals category. Glucose Health, Inc. is publicly-traded with the ticker symbol (OTC:GLUC). Glucose Health® products are manufactured in the USA in Arkansas and Minnesota.
Contact:
Glucose Health, Inc.
Murray Fleming
(888) 987-6315


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Washington Post Publisher Will Lewis Steps Down After Layoffs
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



